These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2748056

  • 1. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ, Joensuu H, Mäenpää J, Kiilholma P.
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
    Reles AE, Gee C, Schellschmidt I, Schmider A, Unger M, Friedmann W, Lichtenegger W, Press MF.
    Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
    [Abstract] [Full Text] [Related]

  • 3. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R, Wimberger P, Hillemanns P, Kapsner T, Caspari C, Hepp H.
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH, Fuller AF, Pastel-Ley C, Flotte TJ, Bell DA.
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [Abstract] [Full Text] [Related]

  • 5. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
    Veerman MM, van der Wurff AA, van de Water M, Kruitwagen RF, Feijen HW, Vos MC.
    Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G, Lerma E, Climent MA, Seguí MA, Alonso MC, Prat J.
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma.
    Rice LW, Mark SD, Berkowitz RS, Goff BA, Lage JM.
    Obstet Gynecol; 1995 Sep; 86(3):379-85. PubMed ID: 7651646
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of nuclear DNA content in pancreatic carcinoma.
    Alanen KA, Joensuu H, Klemi PJ, Nevalainen TJ.
    J Pathol; 1990 Apr; 160(4):313-20. PubMed ID: 2358969
    [Abstract] [Full Text] [Related]

  • 9. Influence of cellular DNA content on survival in advanced ovarian cancer.
    Friedlander ML, Hedley DW, Taylor IW, Russell P, Coates AS, Tattersall MH.
    Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054
    [Abstract] [Full Text] [Related]

  • 10. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS, Gersell DJ, Yim S.
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [Abstract] [Full Text] [Related]

  • 11. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M, Drings P, Kleine W, Mattern J.
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [Abstract] [Full Text] [Related]

  • 13. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M, Lipponen P, Nordling S.
    Anticancer Res; 1995 Dec; 15(5B):2279-83. PubMed ID: 8572637
    [Abstract] [Full Text] [Related]

  • 14. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM.
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [Abstract] [Full Text] [Related]

  • 15. DNA index by flow cytometric analysis: an additional prognostic factor in advanced ovarian carcinoma without residual disease after primary operation.
    Zanetta G, Keeney GL, Cha SS, Wieand HS, Katzmann JA, Podratz KC.
    Gynecol Oncol; 1996 Aug; 62(2):208-12. PubMed ID: 8751551
    [Abstract] [Full Text] [Related]

  • 16. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
    Hsu MM, Chiou CR, Ko JY, Sheen TS, Hong RL, Ting LL.
    Cancer Detect Prev; 2000 Aug; 24(2):119-26. PubMed ID: 10917131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.